SlideShare una empresa de Scribd logo
1 de 49
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Estimated TB Incidence Rates, 2001 25 - 49 50 - 99 100 - 299 < 10 10 - 24 No estimate per 100 000 pop 300 or more The designations employed and the presentation of material on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. White lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2003
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
0 10 20 30 40 Ukraine Russian Federation Republic of Moldova Latvia Estonia Lithuania Romania Belarus Georgia TFYR Macedonia Croatia Hungary Serbia and Montenegro Bulgaria Portugal Poland EUROPE Finland France Slovenia Spain Ireland Czech Republic Slovakia Albania EU average   Iceland Austria ITALY Norway United Kingdom Sweden Greece Netherlands Luxembourg Germany Denmark Switzerland 1999 Tassi standardizzati di mortalità per TBC, tutte le età, per 100.000
Casi di TB in Inghilterra  secondo l’origine etnica
TASSI DI NOTIFICA TBC, PER ETA’,2000  PER AREE GEOGRAFICHE - REGIONE EUROPEA OMS 0 20 40 60 80 100 120 140 160 0-4 5-14 15-24 25-34 35-44 45-54 55-64 > 64 Age group Cases per 100 000 pop Orientale Centrale Occident.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
TBC primaria TBC postprimaria
Tubercolosi post-primaria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Tubercolosi post-primaria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Linfonodi mediastinici ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Tubercolosi post-primaria ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
fibrotorace
Tubercoloma ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

1.- REFLUJO GASTROESOFAGICO(1) (14 files merged).pdf
1.- REFLUJO GASTROESOFAGICO(1) (14 files merged).pdf1.- REFLUJO GASTROESOFAGICO(1) (14 files merged).pdf
1.- REFLUJO GASTROESOFAGICO(1) (14 files merged).pdf
kevinantoniogaraygue
 
Management of Giant Scrotal Hernia
Management of Giant Scrotal HerniaManagement of Giant Scrotal Hernia
Management of Giant Scrotal Hernia
George S. Ferzli
 

La actualidad más candente (20)

Abdominal tb
Abdominal tbAbdominal tb
Abdominal tb
 
7.cirrhosis
7.cirrhosis7.cirrhosis
7.cirrhosis
 
Primary sclerosing cholangitis.drquiyum
Primary sclerosing cholangitis.drquiyumPrimary sclerosing cholangitis.drquiyum
Primary sclerosing cholangitis.drquiyum
 
1.- REFLUJO GASTROESOFAGICO(1) (14 files merged).pdf
1.- REFLUJO GASTROESOFAGICO(1) (14 files merged).pdf1.- REFLUJO GASTROESOFAGICO(1) (14 files merged).pdf
1.- REFLUJO GASTROESOFAGICO(1) (14 files merged).pdf
 
Hypersensitivity pneumonitis: radiology and pathology aspect
Hypersensitivity pneumonitis: radiology and pathology aspectHypersensitivity pneumonitis: radiology and pathology aspect
Hypersensitivity pneumonitis: radiology and pathology aspect
 
Pulmonary echinococcosis
Pulmonary echinococcosisPulmonary echinococcosis
Pulmonary echinococcosis
 
Lower GIT
Lower GITLower GIT
Lower GIT
 
Fun Functional Gallbladder Disorders: Update on Hypo and Hyperkinetic Gallbla...
Fun Functional Gallbladder Disorders: Update on Hypo and Hyperkinetic Gallbla...Fun Functional Gallbladder Disorders: Update on Hypo and Hyperkinetic Gallbla...
Fun Functional Gallbladder Disorders: Update on Hypo and Hyperkinetic Gallbla...
 
Mesenteric ishemia ankur
Mesenteric ishemia ankurMesenteric ishemia ankur
Mesenteric ishemia ankur
 
Hypersensitivity Pneumonitis
Hypersensitivity PneumonitisHypersensitivity Pneumonitis
Hypersensitivity Pneumonitis
 
ACLF : Acute on Chronic Liver Failure
ACLF : Acute on Chronic Liver FailureACLF : Acute on Chronic Liver Failure
ACLF : Acute on Chronic Liver Failure
 
Chest menifestation in hiv
Chest menifestation in hivChest menifestation in hiv
Chest menifestation in hiv
 
Differential diagnosis of cavitary lung lesions
Differential diagnosis of cavitary lung lesionsDifferential diagnosis of cavitary lung lesions
Differential diagnosis of cavitary lung lesions
 
Ventilation in ards by tarun
Ventilation in  ards by tarunVentilation in  ards by tarun
Ventilation in ards by tarun
 
Management of Giant Scrotal Hernia
Management of Giant Scrotal HerniaManagement of Giant Scrotal Hernia
Management of Giant Scrotal Hernia
 
Pólipos colorectales
Pólipos colorectalesPólipos colorectales
Pólipos colorectales
 
Meconium ileus surgical management
Meconium ileus surgical managementMeconium ileus surgical management
Meconium ileus surgical management
 
Ventilator Induced Lung Injury
Ventilator Induced Lung InjuryVentilator Induced Lung Injury
Ventilator Induced Lung Injury
 
Non cirrhotic portal fibrosis
Non cirrhotic portal fibrosisNon cirrhotic portal fibrosis
Non cirrhotic portal fibrosis
 
TOKYO GUIDELINES: MANGEMENT OF ACUTE CHOLECYSTITIS AND ACUTE CHOLANGITIS ( TG18)
TOKYO GUIDELINES: MANGEMENT OF ACUTE CHOLECYSTITIS AND ACUTE CHOLANGITIS ( TG18)TOKYO GUIDELINES: MANGEMENT OF ACUTE CHOLECYSTITIS AND ACUTE CHOLANGITIS ( TG18)
TOKYO GUIDELINES: MANGEMENT OF ACUTE CHOLECYSTITIS AND ACUTE CHOLANGITIS ( TG18)
 

Destacado

Piantoni Luca. Il nodulo TIR 3. ASMaD 2011
Piantoni Luca. Il nodulo TIR 3. ASMaD 2011Piantoni Luca. Il nodulo TIR 3. ASMaD 2011
Piantoni Luca. Il nodulo TIR 3. ASMaD 2011
Gianfranco Tammaro
 
Bronchiect Mar
Bronchiect MarBronchiect Mar
Bronchiect Mar
slidesmed
 
PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"
StopTb Italia
 
PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"
StopTb Italia
 
Greenwich IATA Presentation 7 Oct 2008 Final Website
Greenwich IATA Presentation 7 Oct 2008 Final WebsiteGreenwich IATA Presentation 7 Oct 2008 Final Website
Greenwich IATA Presentation 7 Oct 2008 Final Website
rcsmuk
 
Gang announcements 2011 07
Gang announcements 2011 07Gang announcements 2011 07
Gang announcements 2011 07
David Giard
 
Staceys Outdoor Ed Sac
Staceys Outdoor Ed SacStaceys Outdoor Ed Sac
Staceys Outdoor Ed Sac
mrrobbo
 
4 Esame dei risultati di calcolo nelle NTC 2008 di Aurelio Ghersi
4 Esame dei risultati di calcolo nelle NTC 2008 di Aurelio Ghersi4 Esame dei risultati di calcolo nelle NTC 2008 di Aurelio Ghersi
4 Esame dei risultati di calcolo nelle NTC 2008 di Aurelio Ghersi
Eugenio Agnello
 
Pagine Da Manuale Land1 50
Pagine Da Manuale Land1 50Pagine Da Manuale Land1 50
Pagine Da Manuale Land1 50
pretorianusx
 
Colorado Climate
Colorado ClimateColorado Climate
Colorado Climate
xtina44
 

Destacado (20)

Piantoni Luca. Il nodulo TIR 3. ASMaD 2011
Piantoni Luca. Il nodulo TIR 3. ASMaD 2011Piantoni Luca. Il nodulo TIR 3. ASMaD 2011
Piantoni Luca. Il nodulo TIR 3. ASMaD 2011
 
Bronchiect Mar
Bronchiect MarBronchiect Mar
Bronchiect Mar
 
PPT Casali
PPT CasaliPPT Casali
PPT Casali
 
IMAGING RADIOLOGICO NELLA IPERTENSIONE POLMONARE
IMAGING RADIOLOGICO NELLA IPERTENSIONE POLMONAREIMAGING RADIOLOGICO NELLA IPERTENSIONE POLMONARE
IMAGING RADIOLOGICO NELLA IPERTENSIONE POLMONARE
 
Radiologia de tbc 2
Radiologia de tbc 2Radiologia de tbc 2
Radiologia de tbc 2
 
Tree in-bud sign golden s sign
Tree in-bud sign golden s signTree in-bud sign golden s sign
Tree in-bud sign golden s sign
 
PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"PPT Ranieri "HIV e TB in carcere"
PPT Ranieri "HIV e TB in carcere"
 
La diagnostica per immagini
La diagnostica per immaginiLa diagnostica per immagini
La diagnostica per immagini
 
PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"PPT Cirillo "La diagnosi di tubercolosi"
PPT Cirillo "La diagnosi di tubercolosi"
 
Tuberculosis, hidatidosis, bronquiectasias Rx, TAC dx por imagen
Tuberculosis, hidatidosis, bronquiectasias  Rx, TAC dx por imagen Tuberculosis, hidatidosis, bronquiectasias  Rx, TAC dx por imagen
Tuberculosis, hidatidosis, bronquiectasias Rx, TAC dx por imagen
 
μάθηση
μάθησημάθηση
μάθηση
 
Greenwich IATA Presentation 7 Oct 2008 Final Website
Greenwich IATA Presentation 7 Oct 2008 Final WebsiteGreenwich IATA Presentation 7 Oct 2008 Final Website
Greenwich IATA Presentation 7 Oct 2008 Final Website
 
Aσφάλεια στο διαδίκτυο. Μια πρώτη προσέγγιση.
Aσφάλεια στο διαδίκτυο. Μια πρώτη προσέγγιση.Aσφάλεια στο διαδίκτυο. Μια πρώτη προσέγγιση.
Aσφάλεια στο διαδίκτυο. Μια πρώτη προσέγγιση.
 
Harmony With Healthstory Clinical Narrative And Structured Data In The Ehr ...
Harmony With Healthstory   Clinical Narrative And Structured Data In The Ehr ...Harmony With Healthstory   Clinical Narrative And Structured Data In The Ehr ...
Harmony With Healthstory Clinical Narrative And Structured Data In The Ehr ...
 
Gang announcements 2011 07
Gang announcements 2011 07Gang announcements 2011 07
Gang announcements 2011 07
 
Party
PartyParty
Party
 
Staceys Outdoor Ed Sac
Staceys Outdoor Ed SacStaceys Outdoor Ed Sac
Staceys Outdoor Ed Sac
 
4 Esame dei risultati di calcolo nelle NTC 2008 di Aurelio Ghersi
4 Esame dei risultati di calcolo nelle NTC 2008 di Aurelio Ghersi4 Esame dei risultati di calcolo nelle NTC 2008 di Aurelio Ghersi
4 Esame dei risultati di calcolo nelle NTC 2008 di Aurelio Ghersi
 
Pagine Da Manuale Land1 50
Pagine Da Manuale Land1 50Pagine Da Manuale Land1 50
Pagine Da Manuale Land1 50
 
Colorado Climate
Colorado ClimateColorado Climate
Colorado Climate
 

Similar a Tbc Mar

Stafilo ch
Stafilo chStafilo ch
Stafilo ch
Dario
 
infezioni da Citomegalovirus
infezioni  da Citomegalovirusinfezioni  da Citomegalovirus
infezioni da Citomegalovirus
Dario
 
Influenza 16 01 2009
Influenza  16 01 2009Influenza  16 01 2009
Influenza 16 01 2009
DrSAX
 
Polmoniti laurea breve
Polmoniti laurea brevePolmoniti laurea breve
Polmoniti laurea breve
Dario
 
Legionella
Legionella Legionella
Legionella
Dario
 
Agenti infettivi piogeni
Agenti infettivi piogeniAgenti infettivi piogeni
Agenti infettivi piogeni
armbru
 
Infezioni da citomegalovirus (cmv)
Infezioni da citomegalovirus (cmv)Infezioni da citomegalovirus (cmv)
Infezioni da citomegalovirus (cmv)
Dario
 
Ebv laurea breve
Ebv laurea breveEbv laurea breve
Ebv laurea breve
Dario
 
PPT Galli "Storia dell'HIV"
PPT Galli "Storia dell'HIV"PPT Galli "Storia dell'HIV"
PPT Galli "Storia dell'HIV"
StopTb Italia
 
Esantemi ch
Esantemi chEsantemi ch
Esantemi ch
Dario
 
Brucellosi ch
Brucellosi chBrucellosi ch
Brucellosi ch
Dario
 

Similar a Tbc Mar (20)

Stafilo ch
Stafilo chStafilo ch
Stafilo ch
 
infezioni da Citomegalovirus
infezioni  da Citomegalovirusinfezioni  da Citomegalovirus
infezioni da Citomegalovirus
 
Influenza 16 01 2009
Influenza  16 01 2009Influenza  16 01 2009
Influenza 16 01 2009
 
HIV INFORMA: Intervento Dott. Daniele Mandrioli
HIV INFORMA: Intervento Dott. Daniele MandrioliHIV INFORMA: Intervento Dott. Daniele Mandrioli
HIV INFORMA: Intervento Dott. Daniele Mandrioli
 
Polmoniti laurea breve
Polmoniti laurea brevePolmoniti laurea breve
Polmoniti laurea breve
 
Legionella
Legionella Legionella
Legionella
 
Agenti infettivi piogeni
Agenti infettivi piogeniAgenti infettivi piogeni
Agenti infettivi piogeni
 
Ebv
EbvEbv
Ebv
 
Infezioni da citomegalovirus (cmv)
Infezioni da citomegalovirus (cmv)Infezioni da citomegalovirus (cmv)
Infezioni da citomegalovirus (cmv)
 
Ebv laurea breve
Ebv laurea breveEbv laurea breve
Ebv laurea breve
 
Modulo1 dermatologia pediatrica
Modulo1 dermatologia pediatricaModulo1 dermatologia pediatrica
Modulo1 dermatologia pediatrica
 
Malattie infettive
Malattie infettiveMalattie infettive
Malattie infettive
 
148 oms-malattie-trasmesse-vettori-it
148   oms-malattie-trasmesse-vettori-it148   oms-malattie-trasmesse-vettori-it
148 oms-malattie-trasmesse-vettori-it
 
Acute, Post Acute Sequelae COVID-19 Inferction PASC) and Neuro PASC
Acute, Post Acute Sequelae COVID-19 Inferction PASC) and Neuro PASCAcute, Post Acute Sequelae COVID-19 Inferction PASC) and Neuro PASC
Acute, Post Acute Sequelae COVID-19 Inferction PASC) and Neuro PASC
 
PPT Galli "Storia dell'HIV"
PPT Galli "Storia dell'HIV"PPT Galli "Storia dell'HIV"
PPT Galli "Storia dell'HIV"
 
Esantemi ch
Esantemi chEsantemi ch
Esantemi ch
 
MTA
MTAMTA
MTA
 
Mononucleosi
MononucleosiMononucleosi
Mononucleosi
 
PPT De lorenzo "Extrapulmonary TB: clinical aspects"
PPT De lorenzo "Extrapulmonary TB: clinical aspects"PPT De lorenzo "Extrapulmonary TB: clinical aspects"
PPT De lorenzo "Extrapulmonary TB: clinical aspects"
 
Brucellosi ch
Brucellosi chBrucellosi ch
Brucellosi ch
 

Tbc Mar

  • 1.
  • 2.
  • 3.
  • 4. Estimated TB Incidence Rates, 2001 25 - 49 50 - 99 100 - 299 < 10 10 - 24 No estimate per 100 000 pop 300 or more The designations employed and the presentation of material on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. White lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2003
  • 5.
  • 6. 0 10 20 30 40 Ukraine Russian Federation Republic of Moldova Latvia Estonia Lithuania Romania Belarus Georgia TFYR Macedonia Croatia Hungary Serbia and Montenegro Bulgaria Portugal Poland EUROPE Finland France Slovenia Spain Ireland Czech Republic Slovakia Albania EU average Iceland Austria ITALY Norway United Kingdom Sweden Greece Netherlands Luxembourg Germany Denmark Switzerland 1999 Tassi standardizzati di mortalità per TBC, tutte le età, per 100.000
  • 7. Casi di TB in Inghilterra secondo l’origine etnica
  • 8. TASSI DI NOTIFICA TBC, PER ETA’,2000 PER AREE GEOGRAFICHE - REGIONE EUROPEA OMS 0 20 40 60 80 100 120 140 160 0-4 5-14 15-24 25-34 35-44 45-54 55-64 > 64 Age group Cases per 100 000 pop Orientale Centrale Occident.
  • 9.
  • 10.  
  • 11.  
  • 12.
  • 13.  
  • 14.  
  • 15.
  • 16.  
  • 17.
  • 18.
  • 19.  
  • 20.  
  • 21. TBC primaria TBC postprimaria
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.  
  • 32.
  • 33.
  • 34.  
  • 35.
  • 36.  
  • 37.
  • 38.  
  • 39.
  • 40.
  • 41.
  • 42.  
  • 43.  
  • 44.  
  • 45.
  • 46.  
  • 47.
  • 48.
  • 49.